{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:40:08Z","timestamp":1770745208949,"version":"3.49.0"},"reference-count":82,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Int. J. Hematol. Oncol."],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.2217\/ijh-2017-0015","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T16:25:04Z","timestamp":1502468704000},"page":"75-93","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":28,"title":["Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease\/Sinusoidal Obstruction Syndrome with Multiorgan Failure"],"prefix":"10.2217","volume":"6","author":[{"given":"Paul G","family":"Richardson","sequence":"first","affiliation":[{"name":"Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan A","family":"Grupp","sequence":"additional","affiliation":[{"name":"Pediatric Oncology, The Children\u2019s Hospital of Philadelphia & the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pagliuca","sequence":"additional","affiliation":[{"name":"Department of Haematological Medicine, King\u2019s College Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrita","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent T","family":"Ho","sequence":"additional","affiliation":[{"name":"Hematopoietic Stem Cell Transplantation, Dana-Farber Cancer Institute, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selim","family":"Corbacioglu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, Oncology & Stem Cell Transplantation, University of Regensburg, Regensburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,8,11]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2014.10.002"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02742.x"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-23204"},{"key":"e_1_3_2_6_1","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European Society for Blood and Marrow Transplantation (EBMT)","author":"Corbacioglu S","year":"2017","unstructured":"Corbacioglu S , CarrerasE, AnsariMet al. Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. (2017) (In Press).","journal-title":"Bone Marrow Transplant."},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.08.024"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.06.006"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61938-7"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704069"},{"issue":"10","key":"e_1_3_2_11_1","first-page":"1396","article-title":"A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation","volume":"90","author":"Cesaro S","year":"2005","unstructured":"Cesaro S , PillonM, TalentiEet al. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica90(10), 1396\u20131404 (2005).","journal-title":"Haematologica"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.5.2082.2082"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705485"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1789"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.5849.5849"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.09.026"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.65"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.52"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290615"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-4-199302150-00003"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198712000-00011"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12558"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.130"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(99)70006-6"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.08.002"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.3886.3886"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.09.024"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.168"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.283"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.04.011"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-10-676924"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705835"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13215"},{"key":"e_1_3_2_35_1","volume-title":"The EBMT Handbook: Haematopoietic Stem Cell Transplantation (6th Edition)","author":"Carreras E","year":"2012","unstructured":"Carreras E . Early complications after HSCT. In: The EBMT Handbook: Haematopoietic Stem Cell Transplantation (6th Edition). ApperleyJ, CarrerasE, GluckmanE, MassziT (Eds). EBMT-ESH, Geneva, Switzerland (2012)."},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22351"},{"issue":"3","key":"e_1_3_2_37_1","first-page":"643","article-title":"Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease","volume":"18","author":"Smith FO","year":"1996","unstructured":"Smith FO , JohnsonMS, SchererLRet al. Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease. Bone Marrow Transplant.18(3), 643\u2013646 (1996).","journal-title":"Bone Marrow Transplant."},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2001.210105.x"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-858957"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.5.1501"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702069"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.101"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705896"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.11.011"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702387"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705969"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2011.01529.x"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.983.983"},{"key":"e_1_3_2_49_1","first-page":"CD009311","article-title":"Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation","volume":"5","author":"Cheuk DK","year":"2015","unstructured":"Cheuk DK , ChiangAK, HaSY, ChanGC. Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation. Cochrane Database Syst. Rev.5, CD009311 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705297"},{"issue":"6","key":"e_1_3_2_51_1","first-page":"407","article-title":"A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation","volume":"5","author":"Bearman SI","year":"1990","unstructured":"Bearman SI , HindsMS, WolfordJLet al. A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. Bone Marrow Transplant.5(6), 407\u2013411 (1990).","journal-title":"Bone Marrow Transplant."},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.09.012"},{"key":"e_1_3_2_53_1","first-page":"139763","article-title":"Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy","author":"Tsochatzis EA","year":"2013","unstructured":"Tsochatzis EA , FeudjoM, RigamontiC, VlachogiannakosJ, CarpenterJR, BurroughsAK. Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy. Biomed. Res. Int.2013, 139763 (2013).","journal-title":"Biomed. Res. Int."},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-12-0159"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2013.05.001"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-10-676114"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e32832da1e3"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403004"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(91)90127-I"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.11.019"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1995.tb05789.x"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-149682"},{"key":"e_1_3_2_63_1","unstructured":"Defitelio\u00ae (defibrotide)\n. Summary of product characteristics (2016). www.ema.europa.eu\/ema\/index.jsp?curl=\/pages\/medicines\/human\/medicines\/002393\/human_med_001646.jsp."},{"key":"e_1_3_2_64_1","unstructured":"Defitelio\u00ae (defibrotide sodium) prescribing information. Jazz Pharmaceuticals Inc. CA USA (2016)."},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2012.749855"},{"issue":"1","key":"e_1_3_2_66_1","first-page":"26","article-title":"Pharmacokinetics of defibrotide in healthy volunteers","volume":"16","author":"Noseda G","year":"1986","unstructured":"Noseda G , FragiacomoC, FerrariD. Pharmacokinetics of defibrotide in healthy volunteers. Haemostasis16(Suppl. 1), 26\u201330 (1986).","journal-title":"Haemostasis"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199345020-00007"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S112181"},{"issue":"3","key":"e_1_3_2_69_1","first-page":"737","article-title":"Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population","volume":"92","author":"Richardson PG","year":"1998","unstructured":"Richardson PG , EliasAD, KrishnanAet al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood92(3), 737\u2013744 (1998).","journal-title":"Blood"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1216"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02475.x"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.02.009"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2007.01.075"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704329"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.08.013"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.07.001"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.9.1729"},{"key":"e_1_3_2_78_1","volume-title":"21st Congress of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT)","author":"Richardson PG","year":"2016","unstructured":"Richardson PG , SmithAR, KernanNAet al. Early initiation of defibrotide treatment from time of diagnosis of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome is associated with improved survival post hematopoietic stem cell transplantation; a post-hoc interim analysis. Presented at: 21st Congress of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT). Singapore, 29\u201330 October 2016."},{"key":"e_1_3_2_79_1","volume-title":"The European Society for Blood and Marrow Transplantation","author":"Kernan NA","year":"2016","unstructured":"Kernan NA , RichardsonPG, SmithARet al. Efficacy and safety of defibrotide (DF) in the treatment of hepatic veno-occlusive disease\/sinusoidal syndrome (VOD\/SOS) following chemotherapy in an ongoing study. Presented at: The European Society for Blood and Marrow Transplantation. Valencia, Spain, 3\u20136 April 2016. Poster P683."},{"key":"e_1_3_2_80_1","volume-title":"58th ASH Annual Meeting & Exposition","author":"Grupp SA","year":"2016","unstructured":"Grupp SA , SmithAR, TriplettBMet al. Timing of initiation of defibrotide post-diagnosis of hepatic veno-occlusive disease\/sinusoid obstruction syndrome post-hematopoietic stem cell transplantation: exploratory age group analysis from an expanded access study. Presented at: 58th ASH Annual Meeting & Exposition. San Diego, CA, USA, 3\u20136 December 2016. Publication number: 66."},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2016.01.009"},{"key":"e_1_3_2_82_1","volume-title":"2016 ASH Meeting on Hematologic Malignancies","author":"Corbacioglu S","year":"2016","unstructured":"Corbacioglu S , PagliucaA, GruppSet al. Protocol for a phase 3, randomized, adaptive study comparing the efficacy and safety of defibrotide vs best supportive care to prevent hepatic veno-occlusive disease\/sinusoidal obstruction syndrome (VOD\/SOS) in adult and pediatric patients undergoing hematopoietic stem cell transplant (HSCT). Presented at: 2016 ASH Meeting on Hematologic Malignancies. Chicago, IL, USA, 16\u201317 September (2016)."},{"key":"e_1_3_2_83_1","volume-title":"52nd ASH Annual Meeting and Exposition","author":"Corbacioglu S","year":"2010","unstructured":"Corbacioglu S , CarrerasE, NiederwieserDWet al. Defibrotide study group. safety of defibrotide (DF) in stem cell transplant (SCT) patients (pts). Presented at: 52nd ASH Annual Meeting and Exposition. Orlando, FL, USA, 4\u20137 December (2010)."},{"key":"e_1_3_2_84_1","unstructured":"International Society for Medical Publication Professionals\n. GPP3 Guidelines (2015). www.ismpp.org\/gpp3."}],"container-title":["International Journal of Hematologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/ijh-2017-0015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:11:32Z","timestamp":1717233092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/ijh-2017-0015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,11]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.2217\/ijh-2017-0015"],"URL":"https:\/\/doi.org\/10.2217\/ijh-2017-0015","relation":{},"ISSN":["2045-1393","2045-1407"],"issn-type":[{"value":"2045-1393","type":"print"},{"value":"2045-1407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iijh20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iijh20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-05-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-08-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}